Skip to main content
Responses to parliamentary questions

Question from Deputy Claire Kerrane - PQ 52886-26

Deputy Kerrane asked why Tucatinib (Tukysa) is not accessible to cancer patients in Ireland. Read the HSE response.

Documents

Summary

To ask the Minister for Health the reason a drug (Tucatinib (Tukysa)) is not accessible in Ireland to cancer patients despite approval by the European Medicines Agency and it’s accessibility in many other parts of the EU and in the North of Ireland, if he will examine this and make the drug available for cancer patients where their oncology team has recommended it; and if she will make a statement on the matter.

This is a beta version - your feedback will help us to improve it